P072 LDN-071, a novel first-in-class amino acid-based PAI-1 inhibitor, significantly reduces the severity of experimental colitis in mice
Boldizsár Jójárt(University of Szeged), József Maléth(University of Szeged), Mária Bagyánszki(University of Szeged), Petra Pallagi(University of Szeged), Viktória Szabó(University of Szeged), Bence Pál Barta(University of Szeged), Gábor Heltovics(Io Therapeutics (United States)), Noémi Csákány-Papp(University of Szeged), István M. Mándity(Semmelweis University), H Laub(University of Szeged), Béla Vasas(University of Szeged)
Cited by 0
Related Papers
Immunohistochemical analysis of neuron types in the mouse small intestine
|Cell and Tissue Research|2008|331
Diabetes-related alterations in the enteric nervous system and its microenvironment
|World Journal of Diabetes|2012|70
Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes
|Diabetes Research and Clinical Practice|2008|70